Harvard Apparatus Regenerative Technology Profiled by Xconomy.com

[Business Wire] – Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea more

View todays social media effects on HART

View the latest stocks trending across Twitter. Click to view dashboard

See who Harvard is hiring next, click here to view